BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes
When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...
When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...
Good morning. You may have heard a saying along the lines that “when the US sneezes, the rest of the ...
Today in JAMA Network Open, University of Michigan-led research suggests that the US 2023-24 mRNA COVID-19 vaccines were cost-effective for people ...
A good Thursday to you all, with Andrew Joseph here in London filling in for Mr. Pharmalot. A busy August ...
The U.S. Department of Health and Human Services is terminating contracts for messenger RNA vaccine research, the latest move by ...
Credit: CC0 Public Domain The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic ...
Wavebreakmedia / iStock A study yesterday in JAMA Pediatrics shows varying developmental health trends among US kindergartners immediately prior to ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.